or Try an Advanced Search...

    Clinical Trial Products Stocks List

    Symbol Grade Name % Change
    BIIB D Biogen Idec Inc. 1.87
    INCY D Incyte Corporation 1.26
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Products stocks.

    Symbol Grade Name Weight
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.21
    FBT D First Trust Amex Biotech Index Fund 6.49
    BBH B Market Vectors Biotech ETF 5.93
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 4.73
    PBE C PowerShares Dynamic Biotech & Genome 4.61
    View all Clinical Trial Products ETFs...
    Compare ETFs
    Compare BBH to PBE Compare FBT to BBH Compare FBT to PBE

        Clinical Trial Products Stocks Recent News

        Date Stock Title
        May 3 INCY Q1 2024 Insight Enterprises Inc Earnings Call
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 1 INCY Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
        May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        Apr 30 BIIB Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
        Apr 30 BIIB Biogen: Don't Overthink This One
        Apr 30 INCY Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
        Apr 30 INCY Incyte Corporation (INCY) Q1 2024 Earnings Call Transcript
        Apr 30 INCY Incyte misses quarterly profit on weak sales of lead drug
        Apr 30 INCY Incyte (INCY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
        Apr 30 INCY Incyte Corp (INCY) Q1 2024 Earnings: Misses Revenue Estimates but Shows Strong Growth in ...
        Apr 30 INCY Incyte Corporation 2024 Q1 - Results - Earnings Call Presentation
        Apr 30 INCY Incyte Non-GAAP EPS of $0.64 misses by $0.19, revenue of $880.89M misses by $43.75M
        Apr 30 INCY Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
        Apr 29 BIIB The Analyst Landscape: 27 Takes On Biogen
        Apr 29 INCY Incyte Q1 2024 Earnings Preview
        Apr 29 BIIB 10 Most Promising Stocks to Buy Before They Take Off
        Apr 29 BIIB Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
        Apr 29 BIIB Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 BIIB Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Clinical Trial Product Nasdaq 100 Psoriasis S&P 500 Alzheimer's Disease Autoimmune Disorders Biopharmaceutical Biotechnology Cd20 Chemical Compounds Chronic Lymphocytic Leukemia Degenerative Disease Diabetic Nephropathy Disability Hematologic Malignancies Hemophilia Idiopathic Pulmonary Fibrosis Immune Disorders Immunology Immunosuppressants
        Clinical Trial Products

        Clinical trial products are any products used in clinical trials, such as drugs, medical devices, or biologics. These products are tested in clinical trials to determine their safety and efficacy for treating a particular medical condition. Clinical trial products must meet strict regulatory requirements before they can be approved for use in humans.

        Browse All Tags